1.3 μm emitting SrF2:Nd3+ nanoparticles for high contrast in vivo imaging in the second biological window

Nano Research

Volumn 8, Issue 2, 2015, Pages 649-665

  Villa, Irene ^a   Vedda, Anna ^a   Cantarelli, Irene Xochilt ^b   Pedroni, Marco ^b   Piccinelli, Fabio ^b   Bettinelli, Marco ^b   Speghini, Adolfo ^b   Quintanilla, Marta ^c   Vetrone, Fiorenzo ^c   Rocha, Ueslen ^d   Jacinto, Carlos ^d   Carrasco, Elisa ^e   Rodríguez, Francisco Sanz ^e   Juarranz, Ángeles ^e   del Rosal, Blanca ^e   Ortgies, Dirk H ^e   Gonzalez, Patricia Haro ^e   Solé, José García ^e   García, Daniel Jaque ^e  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c INRS EMT   (Canada)

^d FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

fluorescence imaging; nanomedicine; rare earth doped nanoparticles

Indexed keywords

EID: 84925497143     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-014-0549-1     Document Type: Article

References (85)

1. Srinivas, P. R.; Barker, P.; Srivastava, S. Nanotechnology in early detection of cancer. Lab. Invest.2002, 82, 657–662.
2. Szelenyi, I. Nanomedicine: Evolutionary and revolutionary developments in the treatment of certain inflammatory diseases. Inflamm. Res.2012, 61, 1–9.
3. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Nanotechnol.2007, 2, 37–47.
4. Nie, S. M.; Xing, Y.; Kim, G. J.; Simons, J. W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng.2007, 9, 257–288.
5. Liu, Y.; Miyoshi, H.; Nakamura, M. Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer2007, 120, 2527–2537.
6. Davis, S. S. Biomedical applications of nanotechnology -Implications for drug targeting and gene therapy. Trends Biotechnol.1997, 15, 217–224.
7. Alivisatos, A. P. Less is more in medicine. Sci. Am.2001, 285, 66–73.
8. Bao, G.; Mitragotri, S.; Tong, S. Multifunctional nanoparticles for drug delivery and molecular imaging. Annu. Rev. Biomed. Eng.2013, 15, 253–282.
9. Willner, I.; Willner, B. Biomolecule-based nanomaterials and nanostructures. Nano Lett.2010, 10, 3805–3815.
10. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev2002, 54, 631–651.
11. Pankhurst, Q. A.; Thanh, N. T. K.; Jones, S. K.; Dobson, J. Progress in applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys.2009, 42, 224001.
12. Dreaden, E. C.; Alkilany, A. M.; Huang, X. H.; Murphy, C. J.; El-Sayed, M. A. The golden age: Gold nanoparticles for biomedicine. Chem. Soc. Rev.2012, 41, 2740–2779.
13. Rojas-Chapana, J. A.; Giersig, M. Multi-walled carbon nanotubes and metallic nanoparticles and their application in biomedicine. J. Nanosci. Nanotechnol.2006, 6, 316–321.
14. Juzenas, P.; Chen, W.; Sun, Y. P.; Coelho, M. A. N.; Generalov, R.; Generalova, N.; Christensen, I. L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug Deliv. Rev2008, 60, 1600–1614.
15. Idris, N. M.; Gnanasammandhan, M. K.; Zhang, J.; Ho, P. C.; Mahendran, R.; Zhang, Y. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med.2012, 18, 1580–1585.
16. Huff, T. B.; Tong, L.; Zhao, Y.; Hansen, M. N.; Cheng, J. X.; Wei, A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine2007, 2, 125–132.
17. Jaque, D.; Vetrone, F. Luminescence nanothermometry. Nanoscale2012, 4, 4301–4326.
18. Gnach, A.; Bednarkiewicz, A. Lanthanide-doped up-converting nanoparticles: Merits and challenges. Nano Today2012, 7, 532–563.
19. Crisp, M. T.; Kotov, N. A. Preparation of nanoparticle coatings on surfaces of complex geometry. Nano Lett.2003, 3, 173–177.
20. Sperling, R. A.; Parak, W. J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Phil. Trans. R. Soc. A2010, 368, 1333–1383.
21. Cañaveras, F.; Madueño, R.; Sevilla, J. M.; Blázquez, M.; Pineda, T. Role of the functionalization of the gold nanoparticle surface on the formation of bioconjugates with human serum albumin. J. Phys. Chem. C2012, 116, 10430–10437.
22. Saravanakumar, G.; Kim, K.; Park, J. H.; Rhee, K.; Kwon, I. C. Current status of nanoparticle-based imaging agents for early diagnosis of cancer and atherosclerosis. J. Biomed. Nanotechnol.2009, 5, 20–35.
23. Naccache, R.; Rodriguez, E. M.; Bogdan, N.; Sanz-Rodriguez, F.; de la Cruz, M. D. C. I.; de la Fuente, A. J.; Vetrone, F.; Jaque, D.; Sole, J. G.; Capobianco, J. A. High resolution fluorescence imaging of cancers using lanthanide ion-doped upconverting nanocrystals. Cancers2012, 4, 1067–1105.
24. Ruedas-Rama, M. J.; Walters, J. D.; Orte, A.; Hall, E. A. H. Fluorescent nanoparticles for intracellular sensing: A review. Anal. Chim. Acta2012, 751, 1–23.
25. Jacques, S. L. Optical properties of biological tissues: a review. Phys. Med. Biol.2013, 58, R37.
26. Bhaumik, S.; DePuy, J.; Klimash, J. Strategies to minimize background autofluorescence in live mice during noninvasive fluorescence optical imaging. Lab Animal2007, 36, 40–43.
27. Taroni, P.; Pifferi, A.; Torricelli, A.; Comelli, D.; Cubeddu, R. In vivo absorption and scattering spectroscopy of biological tissues. Photochem. Photobiol. Sci.2003, 2, 124–129.
28. Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol.2003, 7, 626–634.
29. Smith, A. M.; Mancini, M. C.; Nie, S. M. Bioimaging: Second window for in vivo imaging. Nat. Nanotechnol.2009, 4, 710–711.
30. 3 nanophosphors for near-infrared fluorescence bioimaging applications. J. Am. Ceram. Soc.2013, 96, 2759–2765.
31. Hemmer, E.; Venkatachalam, N.; Hyodo, H.; Hattori, A.; Ebina, Y.; Kishimoto, H.; Soga, K. Upconverting and NIR emitting rare earth based nanostructures for NIR-bioimaging. Nanoscale2013, 5, 11339–11361.
32. 3+ doped fluoride nanophosphors. Nano Lett.2008, 8, 3834–3838.
33. Zhou, J.; Liu, Z.; Li, F. Y. Upconversion nanophosphors for small-animal imaging. Chem. Soc. Rev.2012, 41, 1323–1349.
34. 4 nanoparticles. J. Am. Chem. Soc.2008, 130, 5642–5643.
35. Yang, Y.; Shao, Q.; Deng, R.; Wang, C.; Teng, X.; Cheng, K.; Cheng, Z.; Huang, L.; Liu, Z.; Liu, X. In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew. Chem. Int. Ed.2012, 51, 3125–3129.
36. Hong, G.; Lee, J. C.; Robinson, J. T.; Raaz, U.; Xie, L.; Huang, N. F.; Cooke, J. P.; Dai, H. Multifunctional in vivo vascular imaging using near-infrared II fluorescence. Nat. Med.2012, 18, 1841–1846.
37. Welsher, K.; Liu, Z.; Sherlock, S. P.; Robinson, J. T.; Chen, Z.; Daranciang, D.; Dai, H. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat. Nanotechnol.2009, 4, 773–780.
38. Maldiney, T.; Viana, B.; Bessiere, A.; Gourier, D.; Bessodes, M.; Scherman, D.; Richard, C. In vivo imaging with persistent luminescence silicate-based nanoparticles. Opt. Mater.2013, 35, 1852–1858.
39. 3+: A new phosphor for in vivo imaging. J. Phys. D: Appl. Phys.2013, 46, 375401.
40. Lecointre, A.; Bessiere, A.; Priolkar, K. R.; Gourier, D.; Wallez, G.; Viana, B. Role of manganese in red long-lasting phosphorescence of manganese-doped diopside for in vivo imaging. Mater. Res. Bull.2013, 48, 1898–1905.
41. le Masne de Chermont, Q.; Chanéac, C.; Seguin, J.; Pellé, F.; Maîtrejean, S.; Jolivet, J.-P.; Gourier, D.; Bessodes, M.; Scherman, D. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc. Natl. Acad. Sci. U.S.A.2007, 104, 9266–9271.
42. Inoue, Y.; Izawa, K.; Kiryu, S.; Tojo, A.; Ohtomo, K. Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice. Mol. Imaging2008, 7, 21–27.
43. Troy, T.; Jekic-McMullen, D.; Sambucetti, L.; Rice, B. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. Mol. Imaging2004, 3, 9–23.
44. Krasnovsky, A. A., Jr.; Kovalev, Y. V. Spectral and kinetic parameters of phosphorescence of triplet chlorophyll a in the photosynthetic apparatus of plants. Biochemistry (Moscow) 2014, 79, 349–361.
45. Lee, M. R. F.; Scott, M. B.; Veberg-Dahl, A.; Evans, P. R.; Theobald, V. J.; Lundby, F.; Scollan, N. D.; Wold, J.-P. Potential of chlorophyll-rich feed ingredients to improve detection of fecal contamination in the abattoir. J. Food Protect.2013, 76, 516–522.
46. Welsher, K.; Sherlock, S. P.; Dai, H. Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window. Proc. Natl. Acad. Sci. U.S.A.2011, 108, 8943–8948.
47. 2S quantum dots in the second near-infrared region. Angew. Chem. Int. Ed.2012, 51, 9818–9821.
48. 2S quantum dots in the NIR-II window. Biomaterials2014, 35, 393–400.
49. 2S near-infrared quantum dots in mice. Biomaterials2013, 34, 3639–3646.
50. 2S quantum dot: A bright and biocompatible fluorescent nanoprobe in the second near-infrared window. ACS Nano2012, 6, 3695–3702.
51. 2S quantum dots from a single source precursor. J. Am. Chem. Soc.2010, 132, 1470–1471.
52. 2Se quantum dots as a new fluorescent probe in the second near-infrared window for in vivo imaging. Chem. Mater.2013, 25, 2503–2509.
53. 4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications. ACS Nano2012, 6, 2969–2977.
54. 3+ nanocrystals with enhanced near-infrared to near-infrared upconversion photoluminescence. ACS Nano2010, 4, 3163–3168.
55. 2 core/shell nanoparticles with efficient near-infrared to near-infrared upconversion for high-contrast deep tissue bioimaging. ACS Nano2012, 6, 8280–8287.
56. 3 nanoparticles. Nano Lett.2002, 2, 733–737.
57. 3 nanoparticles for fluorescence bioimaging in the second biological window. Small2013, 10, 1141–1154.
58. 4:Yb,Tm nanocrystals. Biomaterials2011, 32, 9059–9067.
59. Fadeel, B.; Garcia-Bennett, A. E. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev.2010, 62, 362–374.
60. Gautam, A.; van Veggel, F. Synthesis of nanoparticles, their biocompatibility, and toxicity behavior for biomedical applications. J. Mater. Chem. B2013, 1, 5186–5200.
61. Boschi, F.; Lo Meo, S.; Rossi, P. L.; Calandrino, R.; Sbarbati, A.; Spinelli, A. E. Optical imaging of alpha emitters: simulations, phantom, and in vivo results. J. Biomed. Opt.2011, 16, 126011.
62. Naczynski, D. J.; Tan, M. C.; Zevon, M.; Wall, B.; Kohl, J.; Kulesa, A.; Chen, S.; Roth, C. M.; Riman, R. E.; Moghe, P. V. Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nat. Commun.2013, 4, 2199.
63. 3 nanoparticles. ACS Nano2013, 7, 1188–1199.
64. Henderson, B.; Imbusch, G. F. Optical Spectroscopy of Inorganic Solids; Oxford Science: New York, 1989.
65. 3+-sensitized upconversion nanophosphors: Efficient in vivo bioimaging probes with minimized heating effect. ACS Nano2013, 7, 7200–7206.
66. 3+ fluorescence in fluoride glasses. J. Phys.-Condens. Matter1994, 6, 913–924.
67. 3+ doped glasses. J. Non-Cryst. Solids2006, 352, 3628–3632.
68. 3+ ions in barium fluoroborophosphate glasses. Opt. Mater.2001, 18, 321–329.
69. Tanabe, S. Optical transitions of rare earth ions for amplifiers: How the local structure works in glass. J. Non-Cryst. Solids1999, 259, 1–9.
70. 4 nonlinear laser crystal. J. Phys.-Condens. Matter1997, 9, 9715–9729.
71. 3+ nanoparticles: Multifunctional nanoprobes for highly penetrating fluorescence bio-imaging. ACS Nano2011, 5, 8665–8671.
72. 2 (M = Ca, Sr) colloids: Influence of the host crystal. Cryst. Growth Des.2013, 13, 4906–4913.
73. 2). Naturwissenschaften1964, 51, 8–9.
74. 2 and other fluorite-structure hosts. J. Opt. Soc. Am.1991, 8, 726–740.
75. Krischer, C. Measurement of sound velocities using Bragg diffraction of light and applications to lanthanum fluoride. Appl. Phys. Lett.1968, 13, 310–311.
76. 3 crystals. J. Appl. Spectrosc. 1967, 6, 23–25.
77. Yang, K.; Zhang, S. A.; Zhang, G. X.; Sun, X. M.; Lee, S. T.; Liu, Z. A. Graphene in mice: Ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett.2010, 10, 3318–3323.
78. Al Faraj, A.; Fauvelle, F.; Luciani, N.; Lacroix, G.; Levy, M.; Cremillieux, Y.; Canet-Soulas, E. In vivo biodistribution and biological impact of injected carbon nanotubes using magnetic resonance techniques. Int. J. Nanomedicine2011, 6, 351–361.
79. Liao, W. Y.; Li, H. J.; Chang, M. Y.; Tang, A. C. L.; Hoffman, A. S.; Hsieh, P. C. H. Comprehensive characterizations of nanoparticle biodistribution following systemic injection in mice. Nanoscale2013, 5, 11079–11086.
80. Hirn, S.; Semmler-Behnke, M.; Schleh, C.; Wenk, A.; Lipka, J.; Schaeffler, M.; Takenaka, S.; Moeller, W.; Schmid, G.; Simon, U.; et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur. J. Pharm. Biopharm.2011, 77, 407–416.
81. Xiao, K.; Li, Y.; Luo, J.; Lee, J. S.; Xiao, W.; Gonik, A. M.; Agarwal, R. G.; Lam, K. S. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials2011, 32, 3435–3446.
82. Balogh, L.; Nigavekar, S. S.; Nair, B. M.; Lesniak, W.; Zhang, C.; Sung, L. Y.; Kariapper, M. S. T.; El-Jawahri, A.; Llanes, M.; Bolton, B.; et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine2007, 3, 281–296.
83. Kumar, R.; Roy, I.; Ohulchanskky, T. Y.; Vathy, L. A.; Bergey, E. J.; Sajjad, M.; Prasad, P. N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano2010, 4, 699–708.
84. Yoshio, T.; Jin, M.; Minfang, Z.; Mei, Y.; Iwao, W.; Sumio, I.; Hiroshi, I.; Masako, Y. Histological assessments for toxicity and functionalization-dependent biodistribution of carbon nanohorns. Nanotechnology2011, 22, 265106.
85. Zhang, X. D.; Wu, H. Y.; Wu, D.; Wang, Y. Y.; Chang, J. H.; Zhai, Z. B.; Meng, A. M.; Liu, P. X.; Zhang, L. A.; Fan, F. Y. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomedicine2010, 5, 771–781.